Skip to content

CareDx CDNA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$3.86M+610%
NeoGenomics logo
NeoGenomicsNEO
-$338K-136%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20.95M+17.8%
GeneDx Holdings logo
GeneDx HoldingsWGS
$476K
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$2.21M+27.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$3.4M-20.9%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's stock issuance proceeds?
CareDx (CDNA) reported stock issuance proceeds of $109K in Q1 2026.
How has CareDx's stock issuance proceeds changed year-over-year?
CareDx's stock issuance proceeds decreased by 96.4% year-over-year, from $3.05M to $109K.
What is the long-term trend for CareDx's stock issuance proceeds?
Over 4 years (2021 to 2025), CareDx's stock issuance proceeds has grown at a -58.3% compound annual growth rate (CAGR), from $188.86M to $5.72M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.